Clinical trials
Schizophrenia clinical trials
Below are recruiting schizophrenia clinical trials, each written for real people, not researchers. We’re tracking 317 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07682935Recruiting
Fishing therapy for schizophrenia: mood and quality of life
This study tests if fishing, as a supportive therapy, can help people with schizophrenia improve mood, reduce anxiety, and boost quality of life. It looks at changes in blood markers and well-being.
Elâzığ, CenterAges 18–60 - NCT04887792RecruitingPhase 1/Phase 2
Acetazolamide for schizophrenia that hasn’t improved
This Phase 1/2 study tests whether acetazolamide can help people with treatment-resistant schizophrenia. It aims to see if adding this medication improves symptoms when standard antipsychotics haven’t worked enough.
Pittsburgh, PennsylvaniaAges 18–55 - NCT06229210RecruitingPhase 3
Lumateperone safety study for children with schizophrenia, bipolar, or autism
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
Phoenix, ArizonaAges 5–17 - NCT06740383Recruiting
Study of early psychosis and treatments
This study looks at people who have had psychosis for less than 4 years to understand how their symptoms change over time and how they respond to treatment. By using brain scans and other tests, researchers hope to find better ways to personalize care for early psychosis.
Hartford, ConnecticutAges 18–40 - NCT06740747Recruiting
Brain stimulation for schizophrenia symptoms
This study tests a new type of brain stimulation (called intermittent theta-burst stimulation) to see if it helps with symptoms like lack of motivation or trouble thinking clearly in people with schizophrenia. You will also have an MRI scan to see how the brain changes.
Hanover, Lower SaxonyAges 18–65 - NCT06745479Recruiting
Understanding decision-making in schizophrenia with brain scans
This study uses brain scans and real-life surveys to understand how people with or without schizophrenia make decisions. It may help researchers learn how the brain works differently in schizophrenia.
Piscataway, New JerseyAges 18–50 - NCT06821945RecruitingPhase 2
Olanzapine dosing study for schizophrenia
This trial tests a slower, lower-dose schedule of the drug olanzapine for people with schizophrenia. It aims to see if a gentler start is safer and works as well, especially for those who may need less medication due to other health conditions.
DaeguAges 19 years+ - NCT06872463Recruiting
Karolinska Schizophrenia Project: Brain study for first episode psychosis
This study examines the brain in people having their first episode of psychosis (like hearing voices or strong false beliefs) to understand more about schizophrenia and related conditions. It involves MRI scans and other tests over one year.
StockholmAges 18 years+ - NCT06882538Recruiting
Mindfulness program for schizophrenia patients
This study tests if a one-on-one mindfulness-based psychoeducation program can help reduce internalized stigma and promote healthy lifestyle behaviors in people with schizophrenia. It aims to provide a supportive approach to improve well-being.
Kastamonu, CentralAges 18 years+ - NCT06882785RecruitingPhase 3
Testing KarXT for Japanese adults with schizophrenia
This trial tests a new medication called KarXT for people with schizophrenia who are currently having a psychotic episode. It is for Japanese adults who have had schizophrenia before and are not in their first episode.
Kōnan, Aichi-kenAges 18–65 - NCT06888726Recruiting
Brain stimulation for negative symptoms in schizophrenia
This trial tests if a gentle electric current applied to your head can help with negative symptoms (like lack of motivation or emotion). You must have schizophrenia, take a common antipsychotic, and have some ongoing negative symptoms.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06894212RecruitingPhase 3
Testing a new med for schizophrenia flare-ups
This trial tests a new medication called SEP-363856 for people with schizophrenia who are currently having a severe flare-up of symptoms. It aims to see if the drug is safe and effective compared to a placebo.
Bentonville, ArkansasAges 18–65 - NCT06911931Recruiting
Visual perception study in schizophrenia and bipolar disorder
This study looks at how people with schizophrenia or bipolar disorder see the world. By comparing their visual perception to people without these conditions, researchers hope to learn more about how the brain processes what we see.
Rochester, New YorkAges 18–65 - NCT06936397Recruiting
Cognitive therapy for schizophrenia: Brain changes and emotions
This trial tests a cognitive training program for people with schizophrenia to see if it improves thinking and emotional control, and how it affects brain activity measured by EEG.
IstanbulAges 18–55 - NCT06957808Recruiting
Diroximel fumarate brain health study for schizophrenia
This trial tests if a drug called diroximel fumarate can help increase a natural antioxidant (glutathione) in the brain for people with schizophrenia. It aims to see if lowering inflammation and boosting brain protection might improve symptoms.
London, Greater LondonAges 18–65 - NCT06961916Recruiting
Brain stimulation to improve connections in schizophrenia
This study tests whether a non-invasive brain stimulation technique called TMS can improve brain connections in people with schizophrenia. It involves two types of MRI scans and several TMS sessions to see if it can help with thinking and symptoms.
Houston, TexasAges 18–60 - NCT06961968RecruitingPhase 3
Schizophrenia medication withdrawal study
This study tests whether patients with schizophrenia can safely stop or reduce their current medication without worsening symptoms. It is designed for people who need ongoing psychiatric care.
Rogers, ArkansasAges 18–65 - NCT06963034RecruitingPhase 3
Study of a new medicine for adults with schizophrenia
This trial tests an investigational medicine called NBI-1117568 in adults with schizophrenia who are currently having a relapse or worsening of symptoms and need to stay in the hospital. The goal is to see if the medicine is safe and effective.
Bryant, ArkansasAges 18–65 - NCT07010614Recruiting
Brain stimulation for memory in schizophrenia
This trial uses brain stimulation to target memory areas in people with schizophrenia or related conditions. It aims to see if this can help improve symptoms.
Stanford, CaliforniaAges 18–65 - NCT07045142RecruitingPhase 3
Metformin for blood sugar issues from statins in schizophrenia
This trial tests whether metformin can help prevent or manage blood sugar problems that may arise when people with schizophrenia take statins (cholesterol-lowering drugs). If you have schizophrenia, are on a stable medication routine, and have high cholesterol but not diabetes, this study might be an option.
Zhumadian, HenanAges 18–65 - NCT07055204Recruiting
Music-based cognitive training for schizophrenia
This study tests a special music-based training program that uses rhythm, voice, and body movements to help with thinking and memory skills in people with schizophrenia. It might improve how your brain processes information.
BayonneAges 18–60 - NCT07085923Recruiting
Heart health study for people with mental illness
This study tests a program to improve heart health in people with schizophrenia or bipolar disorder who take antipsychotic medication or lithium and have a high body weight. The goal is to help reduce heart disease risk.
OsloAges 25–70 - NCT07105098RecruitingPhase 3
Study of a new drug for schizophrenia in hospitalized adults
This study tests an experimental drug (NBI-1117568) for people with schizophrenia who are currently in the hospital due to worsening symptoms. Participants stop their current antipsychotic and take the study drug to see if it can help control symptoms.
Culver City, CaliforniaAges 18–65 - NCT07114874RecruitingPhase 3
A long-term study of a new drug for schizophrenia
This study tests a new medicine called NBI-1117568 for adults with schizophrenia over a longer period of time. Participants will stop their current antipsychotics and take this new drug to see how well it works and how safe it is.
Bryant, ArkansasAges 18–65
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for schizophrenia?
- Yes. Clin2 currently lists 317 recruiting schizophrenia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a schizophrenia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a schizophrenia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.